Aquisição de ADALImumab 20 MG/0.2 ML SOL INJ SER 0.2 ML SC e ADALImumab 40 MG/0.4 ML SOL INJ CANETA 0.4 ML SC

ID 10936963 · Portal BASE
Price
Base Price
€399,923 .00
Effective Price
€265,560 .00 -33.6%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
1
Winner
ABBVIE, LDA
NIF 510229050
Company
Competition
1 bidder recorded
ABBVIE, LDA
NIF 510229050
Dates
Publication
25 Sep 2024
Celebration
08 May 2024
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 60 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
25 Sep 2024
Signing Date
08 May 2024
Days Late
140
Rule
A2/A3 late publication: 140 days after signing (threshold: 10)
Detected 2026-03-06
A6 · Low Competition
A6_LOW_COMPETITION
MEDIUM
Rule
a6_single_bidder
Bidder count
1
Detected 2026-04-17